107 related articles for article (PubMed ID: 20127324)
21. Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis.
Li X; Ominsky MS; Warmington KS; Morony S; Gong J; Cao J; Gao Y; Shalhoub V; Tipton B; Haldankar R; Chen Q; Winters A; Boone T; Geng Z; Niu QT; Ke HZ; Kostenuik PJ; Simonet WS; Lacey DL; Paszty C
J Bone Miner Res; 2009 Apr; 24(4):578-88. PubMed ID: 19049336
[TBL] [Abstract][Full Text] [Related]
22. Amylin and bone metabolism in streptozotocin-induced diabetic rats.
Horcajada-Molteni MN; Chanteranne B; Lebecque P; Davicco MJ; Coxam V; Young A; Barlet JP
J Bone Miner Res; 2001 May; 16(5):958-65. PubMed ID: 11341342
[TBL] [Abstract][Full Text] [Related]
23. A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats.
Ke HZ; Crawford DT; Qi H; Simmons HA; Owen TA; Paralkar VM; Li M; Lu B; Grasser WA; Cameron KO; Lefker BA; DaSilva-Jardine P; Scott DO; Zhang Q; Tian XY; Jee WS; Brown TA; Thompson DD
J Bone Miner Res; 2006 Apr; 21(4):565-75. PubMed ID: 16598377
[TBL] [Abstract][Full Text] [Related]
24. The vasorelaxant effect of adrenomedullin, proadrenomedullin N-terminal 20 peptide and amylin in human skin.
Hasbak P; Eskesen K; Lind H; Holst J; Edvinsson L
Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):162-7. PubMed ID: 16918718
[TBL] [Abstract][Full Text] [Related]
25. Amylin receptor phenotypes derived from human calcitonin receptor/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment.
Tilakaratne N; Christopoulos G; Zumpe ET; Foord SM; Sexton PM
J Pharmacol Exp Ther; 2000 Jul; 294(1):61-72. PubMed ID: 10871296
[TBL] [Abstract][Full Text] [Related]
26. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
[TBL] [Abstract][Full Text] [Related]
27. Isolation and characterization of a novel peptide, osteoblast activating peptide (OBAP), associated with osteoblast differentiation and bone formation.
Fukushima N; Hiraoka K; Shirachi I; Kojima M; Nagata K
Biochem Biophys Res Commun; 2010 Sep; 400(1):157-63. PubMed ID: 20709021
[TBL] [Abstract][Full Text] [Related]
28. Prostaglandin E2-mediated anabolic effect of a novel inhibitor of phosphodiesterase 4, XT-611, in the in vitro bone marrow culture.
Miyamoto K; Suzuki H; Yamamoto S; Saitoh Y; Ochiai E; Moritani S; Yokogawa K; Waki Y; Kasugai S; Sawanishi H; Yamagami H
J Bone Miner Res; 2003 Aug; 18(8):1471-7. PubMed ID: 12929936
[TBL] [Abstract][Full Text] [Related]
29. Changes in osteoblast, chondrocyte, and adipocyte lineages mediate the bone anabolic actions of PTH and small molecule GSK-3 inhibitor.
Kulkarni NH; Wei T; Kumar A; Dow ER; Stewart TR; Shou J; N'cho M; Sterchi DL; Gitter BD; Higgs RE; Halladay DL; Engler TA; Martin TJ; Bryant HU; Ma YL; Onyia JE
J Cell Biochem; 2007 Dec; 102(6):1504-18. PubMed ID: 17520664
[TBL] [Abstract][Full Text] [Related]
30. The N-terminal extracellular domain 23-60 of the calcitonin receptor-like receptor in chimeras with the parathyroid hormone receptor mediates association with receptor activity-modifying protein 1.
Ittner LM; Koller D; Muff R; Fischer JA; Born W
Biochemistry; 2005 Apr; 44(15):5749-54. PubMed ID: 15823033
[TBL] [Abstract][Full Text] [Related]
31. Strain-dependent variations in the response of cancellous bone to ovariectomy in mice.
Iwaniec UT; Yuan D; Power RA; Wronski TJ
J Bone Miner Res; 2006 Jul; 21(7):1068-74. PubMed ID: 16813527
[TBL] [Abstract][Full Text] [Related]
32. Effects of amylin and adrenomedullin on the skeleton.
Cornish J; Reid IR
J Musculoskelet Neuronal Interact; 2001 Sep; 2(1):15-24. PubMed ID: 15758473
[TBL] [Abstract][Full Text] [Related]
33. The role of amylin and related peptides in osteoporosis.
Bronský J; Průsa R; Nevoral J
Clin Chim Acta; 2006 Nov; 373(1-2):9-16. PubMed ID: 16797521
[TBL] [Abstract][Full Text] [Related]
34. Amylin and adrenomedullin: novel regulators of bone growth.
Cornish J; Naot D
Curr Pharm Des; 2002; 8(23):2009-21. PubMed ID: 12171515
[TBL] [Abstract][Full Text] [Related]
35. Expression cloning and receptor pharmacology of human calcitonin receptors from MCF-7 cells and their relationship to amylin receptors.
Chen WJ; Armour S; Way J; Chen G; Watson C; Irving P; Cobb J; Kadwell S; Beaumont K; Rimele T; Kenakin T
Mol Pharmacol; 1997 Dec; 52(6):1164-75. PubMed ID: 9396787
[TBL] [Abstract][Full Text] [Related]
36. Systemic administration of a novel octapeptide, amylin-(1---8), increases bone volume in male mice.
Cornish J; Callon KE; Gasser JA; Bava U; Gardiner EM; Coy DH; Cooper GJ; Reid IR
Am J Physiol Endocrinol Metab; 2000 Oct; 279(4):E730-5. PubMed ID: 11001752
[TBL] [Abstract][Full Text] [Related]
37. 3-Piperidylethoxypterocarpan: A potential bone anabolic agent that improves bone quality and restores trabecular micro-architecture in ovariectomized osteopenic rats.
Raghuvanshi A; Kumar A; Tyagi AM; Kureel J; Awasthi P; Purohit D; Mansoori MN; Shukla P; Srivastava K; Gautam AK; Saxena R; Dwivedi A; Singh D; Goel A
Mol Cell Endocrinol; 2017 Jun; 448():41-54. PubMed ID: 28288902
[TBL] [Abstract][Full Text] [Related]
38. Amylin increases bone volume but cannot ameliorate diabetic osteopenia.
Romero DF; Bryer HP; Rucinski B; Isserow JA; Buchinsky FJ; Cvetkovic M; Liu CC; Epstein S
Calcif Tissue Int; 1995 Jan; 56(1):54-61. PubMed ID: 7796348
[TBL] [Abstract][Full Text] [Related]
39. Activity of pramlintide, rat and human amylin but not Aβ1-42 at human amylin receptors.
Gingell JJ; Burns ER; Hay DL
Endocrinology; 2014 Jan; 155(1):21-6. PubMed ID: 24169554
[TBL] [Abstract][Full Text] [Related]
40. Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo.
Dacquin R; Davey RA; Laplace C; Levasseur R; Morris HA; Goldring SR; Gebre-Medhin S; Galson DL; Zajac JD; Karsenty G
J Cell Biol; 2004 Feb; 164(4):509-14. PubMed ID: 14970190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
